Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Edmond Pharma
Paderno Dugnano, Lombardy, Italyedmondpharma.com ↗
- Ownership
- Private
- Employees
- ~18
- Development stage
- Other
01
Overview
Edmond Pharma manufactures a wide range of generic APIs and finished dosage forms for human and veterinary use. The company has developed proprietary products such as Erdosteine, which is marketed in 40 countries worldwide and has received orphan drug status from the FDA. The company’s manufacturing site is authorized by major health authorities including AIFA, FDA, KFDA, and PMDA. Pipeline programs include Derpanicate for hyperlipidemia (discontinued) and Fenclozine Maleate for fever (pending).
- Therapeutic areas
- CardiovascularInfectious Diseases
- Modalities
- Small moleculeGeneric drugsOrphan drugs
- Industry
- Biotech
02
Partnerships
Not specified; as a CDMO/API supplier likely partners with multiple pharma companies globally
Beyond the preview
Go deeper on Edmond Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Edmond Pharma.